These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16227000)

  • 1. Pulmonary embolism: a fatal complication of arterial chemoembolization for advanced hepatocellular carcinoma.
    Czauderna P; Zbrzezniak G; Narozanski W; Sznurkowska K; Skoczylas-Stoba B; Stoba C
    J Pediatr Surg; 2005 Oct; 40(10):1647-50. PubMed ID: 16227000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary experience with arterial chemoembolization for hepatoblastoma and hepatocellular carcinoma in children.
    Czauderna P; Zbrzezniak G; Narozanski W; Korzon M; Wyszomirska M; Stoba C
    Pediatr Blood Cancer; 2006 Jun; 46(7):825-8. PubMed ID: 16123986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary embolism after transcatheter arterial chemoembolization.
    Shiah HS; Liu TW; Chen LT; Chang JY; Liu JM; Chuang TR; Lee WS; Whang-Peng J
    Eur J Cancer Care (Engl); 2005 Dec; 14(5):440-2. PubMed ID: 16274465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral lipiodol embolism: a complication of transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Matsumoto K; Nojiri J; Takase Y; Egashira Y; Azama S; Kato A; Kitahara K; Miyazaki K; Kudo S
    Cardiovasc Intervent Radiol; 2007; 30(3):512-4. PubMed ID: 17171304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma].
    Miura T; An M; Matsumoto Y; Terakado H; Murata M; Takagi S; Ikawa M; Hamada E; Watanabe K; Nakasato S
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1262-5. PubMed ID: 9703803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized trial of hepatic artery chemotherapy with cisplatin and doxorubicin, with or without lipiodol in the treatment of advanced stage hepatocellular carcinoma.
    Carr BI; Bron K; Swanson DP
    J Clin Gastroenterol; 2011 Oct; 45(9):e87-91. PubMed ID: 21921843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors related to acute upper gastrointestinal bleeding after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma].
    Wu JX; Huang JF; Yu ZJ; Meng XY; Li DG; Lu HM
    Ai Zheng; 2002 Aug; 21(8):881-4. PubMed ID: 12478898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of severe complications after transcatheter arterial chemoembolization for primary hepatocellular carcinoma].
    Liang SN; Liu LL; Su HY; Feng B; Zhao GS; Xu K
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):790-2. PubMed ID: 19173817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary embolism after arterial chemoembolization for hepatocellular carcinoma: an autopsy case report.
    Hatamaru K; Azuma S; Akamatsu T; Seta T; Urai S; Uenoyama Y; Yamashita Y; Ono K
    World J Gastroenterol; 2015 Jan; 21(4):1344-8. PubMed ID: 25632211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma: a case report and literature review.
    Naorungroj T; Naksanguan T; Chinthammitr Y
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S270-5. PubMed ID: 23590054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for the development of pulmonary oil embolism after transcatheter arterial chemoembolization of hepatic tumors.
    Wu GC; Chan ED; Chou YC; Yu CY; Hsieh TY; Hsieh CB; Chian CF; Ke FC; Dai YL; Su WL
    Anticancer Drugs; 2014 Sep; 25(8):976-81. PubMed ID: 24736105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter arterial chemoembolization with fine-powder cisplatin-lipiodol for HCC.
    Koizumi Y; Hirooka M; Uehara T; Kisaka Y; Uesugi K; Kumagi T; Abe M; Matsuura B; Hiasa Y; Onji M
    Hepatogastroenterology; 2011; 58(106):512-5. PubMed ID: 21661422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
    Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
    Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodized oil embolization to brain following transcatheter arterial embolization of liver.
    Wu RH; Tzeng WS; Chang CM
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1465-7. PubMed ID: 16105143
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study.
    Baur M; Walter R; Gebauer A; Tscholakoff D; Lochs H; Mühlbacher F; Turetschek K; Binder R; Hudec M; Gangl A; Ferenci P; Dittrich C
    Int J Oncol; 2003 Sep; 23(3):811-9. PubMed ID: 12888922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticancer effect and side effect of arterial chemoembolization using cis-diamine-dichloroplatinum (II)/4-0-tetrahydropyranyl-adriamycin-lipiodol (CTL) suspension on hepatocellular carcinoma].
    Takeshita T; Inoue H; Miyazono N; Hori A; Harada O; Satake M; Kanetsuki I; Nishida H; Sagara K; Shinmaki H
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1867-72. PubMed ID: 1381572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of local lipiodol chemoembolization therapy in primary and secondary hepatic tumors].
    András C; Szúcs Farkas Z; Csiki Z; Gál I; Takács I; Sápy P; Péter M
    Orv Hetil; 2000 Aug; 141(32):1773-7. PubMed ID: 10979306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.